世界の経口血糖降下薬市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Oral Hypoglycemic Agents Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5913
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、108ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、経口血糖降下薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（液体、カプセル、錠剤）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・経口血糖降下薬の市場動向
・企業の競争状況、市場シェア
・経口血糖降下薬の種類別市場規模と予測2016-2027（液体、カプセル、錠剤）
・経口血糖降下薬の用途別市場規模と予測2016-2027（病院薬局、小売薬局、オンライン薬局）
・経口血糖降下薬の北米市場規模2016-2027（アメリカ、カナダ）
・経口血糖降下薬の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・経口血糖降下薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・経口血糖降下薬の中南米市場規模2016-2027（メキシコ、ブラジル）
・経口血糖降下薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Eli Lilly and Company、Janssen Pharmaceuticals、Astellas Pharma Inc.、AstraZeneca plc、Sanofi S.A.、Takeda、Pfizer Inc、Beohringer Ingelgeim、Merk and Co.、Bristol Myers Squibb、Novartis International AG、Abbott Laboratories、Biocon Limited）
・結論

The drugs can treat diabetic by reducing glucose concentrations.
The drugs can treat diabete by reducing glucose concentrations. These drugs mainly focus on the Type 2 diabetes. Oral drugs can control the glucose by stimulating the islet cells.

Market Analysis and Insights: Global Oral Hypoglycemic Agents Market
The global Oral Hypoglycemic Agents market size is projected to reach US$ XX million by 2027, from US$ 39 million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Oral Hypoglycemic Agents market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Oral Hypoglycemic Agents market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Oral Hypoglycemic Agents market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Oral Hypoglycemic Agents market.

Global Oral Hypoglycemic Agents Scope and Market Size
Oral Hypoglycemic Agents market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Oral Hypoglycemic Agents market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Liquid
Capsule
Tablet

Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Eli Lilly and Company
Janssen Pharmaceuticals
Astellas Pharma Inc.
AstraZeneca plc
Sanofi S.A.
Takeda
Pfizer Inc
Beohringer Ingelgeim
Merk and Co.
Bristol Myers Squibb
Novartis International AG
Abbott Laboratories
Biocon Limited

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Oral Hypoglycemic Agents Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Liquid
1.2.3 Capsule
1.2.4 Tablet
1.3 Market by Application
1.3.1 Global Oral Hypoglycemic Agents Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Oral Hypoglycemic Agents Market Perspective (2016-2027)
2.2 Oral Hypoglycemic Agents Growth Trends by Regions
2.2.1 Oral Hypoglycemic Agents Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Oral Hypoglycemic Agents Historic Market Share by Regions (2016-2021)
2.2.3 Oral Hypoglycemic Agents Forecasted Market Size by Regions (2022-2027)
2.3 Oral Hypoglycemic Agents Industry Dynamic
2.3.1 Oral Hypoglycemic Agents Market Trends
2.3.2 Oral Hypoglycemic Agents Market Drivers
2.3.3 Oral Hypoglycemic Agents Market Challenges
2.3.4 Oral Hypoglycemic Agents Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Oral Hypoglycemic Agents Players by Revenue
3.1.1 Global Top Oral Hypoglycemic Agents Players by Revenue (2016-2021)
3.1.2 Global Oral Hypoglycemic Agents Revenue Market Share by Players (2016-2021)
3.2 Global Oral Hypoglycemic Agents Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Oral Hypoglycemic Agents Revenue
3.4 Global Oral Hypoglycemic Agents Market Concentration Ratio
3.4.1 Global Oral Hypoglycemic Agents Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Oral Hypoglycemic Agents Revenue in 2020
3.5 Oral Hypoglycemic Agents Key Players Head office and Area Served
3.6 Key Players Oral Hypoglycemic Agents Product Solution and Service
3.7 Date of Enter into Oral Hypoglycemic Agents Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Oral Hypoglycemic Agents Breakdown Data by Type
4.1 Global Oral Hypoglycemic Agents Historic Market Size by Type (2016-2021)
4.2 Global Oral Hypoglycemic Agents Forecasted Market Size by Type (2022-2027)

5 Oral Hypoglycemic Agents Breakdown Data by Application
5.1 Global Oral Hypoglycemic Agents Historic Market Size by Application (2016-2021)
5.2 Global Oral Hypoglycemic Agents Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Oral Hypoglycemic Agents Market Size (2016-2027)
6.2 North America Oral Hypoglycemic Agents Market Size by Type
6.2.1 North America Oral Hypoglycemic Agents Market Size by Type (2016-2021)
6.2.2 North America Oral Hypoglycemic Agents Market Size by Type (2022-2027)
6.2.3 North America Oral Hypoglycemic Agents Market Size by Type (2016-2027)
6.3 North America Oral Hypoglycemic Agents Market Size by Application
6.3.1 North America Oral Hypoglycemic Agents Market Size by Application (2016-2021)
6.3.2 North America Oral Hypoglycemic Agents Market Size by Application (2022-2027)
6.3.3 North America Oral Hypoglycemic Agents Market Size by Application (2016-2027)
6.4 North America Oral Hypoglycemic Agents Market Size by Country
6.4.1 North America Oral Hypoglycemic Agents Market Size by Country (2016-2021)
6.4.2 North America Oral Hypoglycemic Agents Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Oral Hypoglycemic Agents Market Size (2016-2027)
7.2 Europe Oral Hypoglycemic Agents Market Size by Type
7.2.1 Europe Oral Hypoglycemic Agents Market Size by Type (2016-2021)
7.2.2 Europe Oral Hypoglycemic Agents Market Size by Type (2022-2027)
7.2.3 Europe Oral Hypoglycemic Agents Market Size by Type (2016-2027)
7.3 Europe Oral Hypoglycemic Agents Market Size by Application
7.3.1 Europe Oral Hypoglycemic Agents Market Size by Application (2016-2021)
7.3.2 Europe Oral Hypoglycemic Agents Market Size by Application (2022-2027)
7.3.3 Europe Oral Hypoglycemic Agents Market Size by Application (2016-2027)
7.4 Europe Oral Hypoglycemic Agents Market Size by Country
7.4.1 Europe Oral Hypoglycemic Agents Market Size by Country (2016-2021)
7.4.2 Europe Oral Hypoglycemic Agents Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Oral Hypoglycemic Agents Market Size (2016-2027)
8.2 Asia-Pacific Oral Hypoglycemic Agents Market Size by Type
8.2.1 Asia-Pacific Oral Hypoglycemic Agents Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Oral Hypoglycemic Agents Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Oral Hypoglycemic Agents Market Size by Type (2016-2027)
8.3 Asia-Pacific Oral Hypoglycemic Agents Market Size by Application
8.3.1 Asia-Pacific Oral Hypoglycemic Agents Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Oral Hypoglycemic Agents Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Oral Hypoglycemic Agents Market Size by Application (2016-2027)
8.4 Asia-Pacific Oral Hypoglycemic Agents Market Size by Region
8.4.1 Asia-Pacific Oral Hypoglycemic Agents Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Oral Hypoglycemic Agents Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Oral Hypoglycemic Agents Market Size (2016-2027)
9.2 Latin America Oral Hypoglycemic Agents Market Size by Type
9.2.1 Latin America Oral Hypoglycemic Agents Market Size by Type (2016-2021)
9.2.2 Latin America Oral Hypoglycemic Agents Market Size by Type (2022-2027)
9.2.3 Latin America Oral Hypoglycemic Agents Market Size by Type (2016-2027)
9.3 Latin America Oral Hypoglycemic Agents Market Size by Application
9.3.1 Latin America Oral Hypoglycemic Agents Market Size by Application (2016-2021)
9.3.2 Latin America Oral Hypoglycemic Agents Market Size by Application (2022-2027)
9.3.3 Latin America Oral Hypoglycemic Agents Market Size by Application (2016-2027)
9.4 Latin America Oral Hypoglycemic Agents Market Size by Country
9.4.1 Latin America Oral Hypoglycemic Agents Market Size by Country (2016-2021)
9.4.2 Latin America Oral Hypoglycemic Agents Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Oral Hypoglycemic Agents Market Size (2016-2027)
10.2 Middle East & Africa Oral Hypoglycemic Agents Market Size by Type
10.2.1 Middle East & Africa Oral Hypoglycemic Agents Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Oral Hypoglycemic Agents Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Oral Hypoglycemic Agents Market Size by Type (2016-2027)
10.3 Middle East & Africa Oral Hypoglycemic Agents Market Size by Application
10.3.1 Middle East & Africa Oral Hypoglycemic Agents Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Oral Hypoglycemic Agents Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Oral Hypoglycemic Agents Market Size by Application (2016-2027)
10.4 Middle East & Africa Oral Hypoglycemic Agents Market Size by Country
10.4.1 Middle East & Africa Oral Hypoglycemic Agents Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Oral Hypoglycemic Agents Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Eli Lilly and Company
11.1.1 Eli Lilly and Company Company Details
11.1.2 Eli Lilly and Company Business Overview
11.1.3 Eli Lilly and Company Oral Hypoglycemic Agents Introduction
11.1.4 Eli Lilly and Company Revenue in Oral Hypoglycemic Agents Business (2016-2021)
11.1.5 Eli Lilly and Company Recent Development
11.2 Janssen Pharmaceuticals
11.2.1 Janssen Pharmaceuticals Company Details
11.2.2 Janssen Pharmaceuticals Business Overview
11.2.3 Janssen Pharmaceuticals Oral Hypoglycemic Agents Introduction
11.2.4 Janssen Pharmaceuticals Revenue in Oral Hypoglycemic Agents Business (2016-2021)
11.2.5 Janssen Pharmaceuticals Recent Development
11.3 Astellas Pharma Inc.
11.3.1 Astellas Pharma Inc. Company Details
11.3.2 Astellas Pharma Inc. Business Overview
11.3.3 Astellas Pharma Inc. Oral Hypoglycemic Agents Introduction
11.3.4 Astellas Pharma Inc. Revenue in Oral Hypoglycemic Agents Business (2016-2021)
11.3.5 Astellas Pharma Inc. Recent Development
11.4 AstraZeneca plc
11.4.1 AstraZeneca plc Company Details
11.4.2 AstraZeneca plc Business Overview
11.4.3 AstraZeneca plc Oral Hypoglycemic Agents Introduction
11.4.4 AstraZeneca plc Revenue in Oral Hypoglycemic Agents Business (2016-2021)
11.4.5 AstraZeneca plc Recent Development
11.5 Sanofi S.A.
11.5.1 Sanofi S.A. Company Details
11.5.2 Sanofi S.A. Business Overview
11.5.3 Sanofi S.A. Oral Hypoglycemic Agents Introduction
11.5.4 Sanofi S.A. Revenue in Oral Hypoglycemic Agents Business (2016-2021)
11.5.5 Sanofi S.A. Recent Development
11.6 Takeda
11.6.1 Takeda Company Details
11.6.2 Takeda Business Overview
11.6.3 Takeda Oral Hypoglycemic Agents Introduction
11.6.4 Takeda Revenue in Oral Hypoglycemic Agents Business (2016-2021)
11.6.5 Takeda Recent Development
11.7 Pfizer Inc
11.7.1 Pfizer Inc Company Details
11.7.2 Pfizer Inc Business Overview
11.7.3 Pfizer Inc Oral Hypoglycemic Agents Introduction
11.7.4 Pfizer Inc Revenue in Oral Hypoglycemic Agents Business (2016-2021)
11.7.5 Pfizer Inc Recent Development
11.8 Beohringer Ingelgeim
11.8.1 Beohringer Ingelgeim Company Details
11.8.2 Beohringer Ingelgeim Business Overview
11.8.3 Beohringer Ingelgeim Oral Hypoglycemic Agents Introduction
11.8.4 Beohringer Ingelgeim Revenue in Oral Hypoglycemic Agents Business (2016-2021)
11.8.5 Beohringer Ingelgeim Recent Development
11.9 Merk and Co.
11.9.1 Merk and Co. Company Details
11.9.2 Merk and Co. Business Overview
11.9.3 Merk and Co. Oral Hypoglycemic Agents Introduction
11.9.4 Merk and Co. Revenue in Oral Hypoglycemic Agents Business (2016-2021)
11.9.5 Merk and Co. Recent Development
11.10 Bristol Myers Squibb
11.10.1 Bristol Myers Squibb Company Details
11.10.2 Bristol Myers Squibb Business Overview
11.10.3 Bristol Myers Squibb Oral Hypoglycemic Agents Introduction
11.10.4 Bristol Myers Squibb Revenue in Oral Hypoglycemic Agents Business (2016-2021)
11.10.5 Bristol Myers Squibb Recent Development
11.11 Novartis International AG
11.11.1 Novartis International AG Company Details
11.11.2 Novartis International AG Business Overview
11.11.3 Novartis International AG Oral Hypoglycemic Agents Introduction
11.11.4 Novartis International AG Revenue in Oral Hypoglycemic Agents Business (2016-2021)
11.11.5 Novartis International AG Recent Development
11.12 Abbott Laboratories
11.12.1 Abbott Laboratories Company Details
11.12.2 Abbott Laboratories Business Overview
11.12.3 Abbott Laboratories Oral Hypoglycemic Agents Introduction
11.12.4 Abbott Laboratories Revenue in Oral Hypoglycemic Agents Business (2016-2021)
11.12.5 Abbott Laboratories Recent Development
11.13 Biocon Limited
11.13.1 Biocon Limited Company Details
11.13.2 Biocon Limited Business Overview
11.13.3 Biocon Limited Oral Hypoglycemic Agents Introduction
11.13.4 Biocon Limited Revenue in Oral Hypoglycemic Agents Business (2016-2021)
11.13.5 Biocon Limited Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Oral Hypoglycemic Agents Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Liquid
Table 3. Key Players of Capsule
Table 4. Key Players of Tablet
Table 5. Global Oral Hypoglycemic Agents Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Oral Hypoglycemic Agents Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Oral Hypoglycemic Agents Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Oral Hypoglycemic Agents Market Share by Regions (2016-2021)
Table 9. Global Oral Hypoglycemic Agents Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Oral Hypoglycemic Agents Market Share by Regions (2022-2027)
Table 11. Oral Hypoglycemic Agents Market Trends
Table 12. Oral Hypoglycemic Agents Market Drivers
Table 13. Oral Hypoglycemic Agents Market Challenges
Table 14. Oral Hypoglycemic Agents Market Restraints
Table 15. Global Oral Hypoglycemic Agents Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Oral Hypoglycemic Agents Market Share by Players (2016-2021)
Table 17. Global Top Oral Hypoglycemic Agents Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oral Hypoglycemic Agents as of 2020)
Table 18. Ranking of Global Top Oral Hypoglycemic Agents Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Oral Hypoglycemic Agents Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Oral Hypoglycemic Agents Product Solution and Service
Table 22. Date of Enter into Oral Hypoglycemic Agents Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Oral Hypoglycemic Agents Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Oral Hypoglycemic Agents Revenue Market Share by Type (2016-2021)
Table 26. Global Oral Hypoglycemic Agents Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Oral Hypoglycemic Agents Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Oral Hypoglycemic Agents Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Oral Hypoglycemic Agents Revenue Market Share by Application (2016-2021)
Table 30. Global Oral Hypoglycemic Agents Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Oral Hypoglycemic Agents Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Oral Hypoglycemic Agents Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Oral Hypoglycemic Agents Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Oral Hypoglycemic Agents Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Oral Hypoglycemic Agents Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Oral Hypoglycemic Agents Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Oral Hypoglycemic Agents Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Oral Hypoglycemic Agents Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Oral Hypoglycemic Agents Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Oral Hypoglycemic Agents Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Oral Hypoglycemic Agents Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Oral Hypoglycemic Agents Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Oral Hypoglycemic Agents Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Oral Hypoglycemic Agents Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Oral Hypoglycemic Agents Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Oral Hypoglycemic Agents Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Oral Hypoglycemic Agents Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Oral Hypoglycemic Agents Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Oral Hypoglycemic Agents Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Oral Hypoglycemic Agents Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Oral Hypoglycemic Agents Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Oral Hypoglycemic Agents Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Oral Hypoglycemic Agents Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Oral Hypoglycemic Agents Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Oral Hypoglycemic Agents Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Oral Hypoglycemic Agents Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Oral Hypoglycemic Agents Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Oral Hypoglycemic Agents Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Oral Hypoglycemic Agents Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Oral Hypoglycemic Agents Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Oral Hypoglycemic Agents Market Size by Country (2022-2027) & (US$ Million)
Table 62. Eli Lilly and Company Company Details
Table 63. Eli Lilly and Company Business Overview
Table 64. Eli Lilly and Company Oral Hypoglycemic Agents Product
Table 65. Eli Lilly and Company Revenue in Oral Hypoglycemic Agents Business (2016-2021) & (US$ Million)
Table 66. Eli Lilly and Company Recent Development
Table 67. Janssen Pharmaceuticals Company Details
Table 68. Janssen Pharmaceuticals Business Overview
Table 69. Janssen Pharmaceuticals Oral Hypoglycemic Agents Product
Table 70. Janssen Pharmaceuticals Revenue in Oral Hypoglycemic Agents Business (2016-2021) & (US$ Million)
Table 71. Janssen Pharmaceuticals Recent Development
Table 72. Astellas Pharma Inc. Company Details
Table 73. Astellas Pharma Inc. Business Overview
Table 74. Astellas Pharma Inc. Oral Hypoglycemic Agents Product
Table 75. Astellas Pharma Inc. Revenue in Oral Hypoglycemic Agents Business (2016-2021) & (US$ Million)
Table 76. Astellas Pharma Inc. Recent Development
Table 77. AstraZeneca plc Company Details
Table 78. AstraZeneca plc Business Overview
Table 79. AstraZeneca plc Oral Hypoglycemic Agents Product
Table 80. AstraZeneca plc Revenue in Oral Hypoglycemic Agents Business (2016-2021) & (US$ Million)
Table 81. AstraZeneca plc Recent Development
Table 82. Sanofi S.A. Company Details
Table 83. Sanofi S.A. Business Overview
Table 84. Sanofi S.A. Oral Hypoglycemic Agents Product
Table 85. Sanofi S.A. Revenue in Oral Hypoglycemic Agents Business (2016-2021) & (US$ Million)
Table 86. Sanofi S.A. Recent Development
Table 87. Takeda Company Details
Table 88. Takeda Business Overview
Table 89. Takeda Oral Hypoglycemic Agents Product
Table 90. Takeda Revenue in Oral Hypoglycemic Agents Business (2016-2021) & (US$ Million)
Table 91. Takeda Recent Development
Table 92. Pfizer Inc Company Details
Table 93. Pfizer Inc Business Overview
Table 94. Pfizer Inc Oral Hypoglycemic Agents Product
Table 95. Pfizer Inc Revenue in Oral Hypoglycemic Agents Business (2016-2021) & (US$ Million)
Table 96. Pfizer Inc Recent Development
Table 97. Beohringer Ingelgeim Company Details
Table 98. Beohringer Ingelgeim Business Overview
Table 99. Beohringer Ingelgeim Revenue in Oral Hypoglycemic Agents Business (2016-2021) & (US$ Million)
Table 100. Beohringer Ingelgeim Recent Development
Table 101. Merk and Co. Company Details
Table 102. Merk and Co. Business Overview
Table 103. Merk and Co. Oral Hypoglycemic Agents Product
Table 104. Merk and Co. Revenue in Oral Hypoglycemic Agents Business (2016-2021) & (US$ Million)
Table 105. Merk and Co. Recent Development
Table 106. Bristol Myers Squibb Company Details
Table 107. Bristol Myers Squibb Business Overview
Table 108. Bristol Myers Squibb Oral Hypoglycemic Agents Product
Table 109. Bristol Myers Squibb Revenue in Oral Hypoglycemic Agents Business (2016-2021) & (US$ Million)
Table 110. Bristol Myers Squibb Recent Development
Table 111. Novartis International AG Company Details
Table 112. Novartis International AG Business Overview
Table 113. Novartis International AG Oral Hypoglycemic Agents Product
Table 114. Novartis International AG Revenue in Oral Hypoglycemic Agents Business (2016-2021) & (US$ Million)
Table 115. Novartis International AG Recent Development
Table 116. Abbott Laboratories Company Details
Table 117. Abbott Laboratories Business Overview
Table 118. Abbott Laboratories Oral Hypoglycemic Agents Product
Table 119. Abbott Laboratories Revenue in Oral Hypoglycemic Agents Business (2016-2021) & (US$ Million)
Table 120. Abbott Laboratories Recent Development
Table 121. Biocon Limited Company Details
Table 122. Biocon Limited Business Overview
Table 123. Biocon Limited Oral Hypoglycemic Agents Product
Table 124. Biocon Limited Revenue in Oral Hypoglycemic Agents Business (2016-2021) & (US$ Million)
Table 125. Biocon Limited Recent Development
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Oral Hypoglycemic Agents Market Share by Type: 2020 VS 2027
Figure 2. Liquid Features
Figure 3. Capsule Features
Figure 4. Tablet Features
Figure 5. Global Oral Hypoglycemic Agents Market Share by Application: 2020 VS 2027
Figure 6. Hospital Pharmacies Case Studies
Figure 7. Retail Pharmacies Case Studies
Figure 8. Online Pharmacies Case Studies
Figure 9. Oral Hypoglycemic Agents Report Years Considered
Figure 10. Global Oral Hypoglycemic Agents Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Oral Hypoglycemic Agents Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Oral Hypoglycemic Agents Market Share by Regions: 2020 VS 2027
Figure 13. Global Oral Hypoglycemic Agents Market Share by Regions (2022-2027)
Figure 14. Global Oral Hypoglycemic Agents Market Share by Players in 2020
Figure 15. Global Top Oral Hypoglycemic Agents Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oral Hypoglycemic Agents as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Oral Hypoglycemic Agents Revenue in 2020
Figure 17. Global Oral Hypoglycemic Agents Revenue Market Share by Type (2016-2021)
Figure 18. Global Oral Hypoglycemic Agents Revenue Market Share by Type (2022-2027)
Figure 19. North America Oral Hypoglycemic Agents Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Oral Hypoglycemic Agents Market Share by Type (2016-2027)
Figure 21. North America Oral Hypoglycemic Agents Market Share by Application (2016-2027)
Figure 22. North America Oral Hypoglycemic Agents Market Share by Country (2016-2027)
Figure 23. United States Oral Hypoglycemic Agents Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Oral Hypoglycemic Agents Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Oral Hypoglycemic Agents Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Oral Hypoglycemic Agents Market Share by Type (2016-2027)
Figure 27. Europe Oral Hypoglycemic Agents Market Share by Application (2016-2027)
Figure 28. Europe Oral Hypoglycemic Agents Market Share by Country (2016-2027)
Figure 29. Germany Oral Hypoglycemic Agents Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Oral Hypoglycemic Agents Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Oral Hypoglycemic Agents Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Oral Hypoglycemic Agents Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Oral Hypoglycemic Agents Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Oral Hypoglycemic Agents Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Oral Hypoglycemic Agents Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Oral Hypoglycemic Agents Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Oral Hypoglycemic Agents Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Oral Hypoglycemic Agents Market Share by Region (2016-2027)
Figure 39. China Oral Hypoglycemic Agents Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Oral Hypoglycemic Agents Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Oral Hypoglycemic Agents Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Oral Hypoglycemic Agents Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Oral Hypoglycemic Agents Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Oral Hypoglycemic Agents Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Oral Hypoglycemic Agents Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Oral Hypoglycemic Agents Market Share by Type (2016-2027)
Figure 47. Latin America Oral Hypoglycemic Agents Market Share by Application (2016-2027)
Figure 48. Latin America Oral Hypoglycemic Agents Market Share by Country (2016-2027)
Figure 49. Mexico Oral Hypoglycemic Agents Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Oral Hypoglycemic Agents Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Oral Hypoglycemic Agents Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Oral Hypoglycemic Agents Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Oral Hypoglycemic Agents Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Oral Hypoglycemic Agents Market Share by Country (2016-2027)
Figure 55. Turkey Oral Hypoglycemic Agents Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Oral Hypoglycemic Agents Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Oral Hypoglycemic Agents Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Eli Lilly and Company Revenue Growth Rate in Oral Hypoglycemic Agents Business (2016-2021)
Figure 59. Janssen Pharmaceuticals Revenue Growth Rate in Oral Hypoglycemic Agents Business (2016-2021)
Figure 60. Astellas Pharma Inc. Revenue Growth Rate in Oral Hypoglycemic Agents Business (2016-2021)
Figure 61. AstraZeneca plc Revenue Growth Rate in Oral Hypoglycemic Agents Business (2016-2021)
Figure 62. Sanofi S.A. Revenue Growth Rate in Oral Hypoglycemic Agents Business (2016-2021)
Figure 63. Takeda Revenue Growth Rate in Oral Hypoglycemic Agents Business (2016-2021)
Figure 64. Pfizer Inc Revenue Growth Rate in Oral Hypoglycemic Agents Business (2016-2021)
Figure 65. Beohringer Ingelgeim Revenue Growth Rate in Oral Hypoglycemic Agents Business (2016-2021)
Figure 66. Merk and Co. Revenue Growth Rate in Oral Hypoglycemic Agents Business (2016-2021)
Figure 67. Bristol Myers Squibb Revenue Growth Rate in Oral Hypoglycemic Agents Business (2016-2021)
Figure 68. Novartis International AG Revenue Growth Rate in Oral Hypoglycemic Agents Business (2016-2021)
Figure 69. Abbott Laboratories Revenue Growth Rate in Oral Hypoglycemic Agents Business (2016-2021)
Figure 70. Biocon Limited Revenue Growth Rate in Oral Hypoglycemic Agents Business (2016-2021)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed

以下、関連資料のご紹介

世界の経口抗糖尿病剤市場規模・現状・予測（2021年-2027年）

Global Oral Antidiabetic Agents Market Size, Status and Forecast 2021-2027
QFJ1-4620 2021年6月 106Pages
QYResearch社発行の本調査レポートでは、経口抗糖尿病剤の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（スルホニル尿素剤、メグリチニド、ビグアニド、チアゾリジンジオン、α-グルコシダーゼ阻害剤）、用途別市場規模（家庭用、医療機関、その他）、主...

世界の口腔がん分子診断市場規模・現状・予測（2021年-2027年）

Global Oral Cancer Molecular Diagnosis Market Size, Status and Forecast 2021-2027
QFJ1-4622 2021年6月 86Pages
QYResearch社発行の本調査レポートでは、口腔がん分子診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（PCR、FISH、DNAシーケンシング、ジーンチップ）、用途別市場規模（臨床診断、薬物スクリーニング、研究）、主要地域別市場規模（北米、...

世界の組織シーリング剤＆止血市場規模・現状・予測（2021年-2027年）

Global Tissue Sealing Agents and Hemostasis Market Size, Status and Forecast 2021-2027
QFJ1-5363 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、組織シーリング剤＆止血の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（天然組織シーラント、合成組織シーラント、その他）、用途別市場規模（学術、病院、研究所、その他）、主要地域別市場規模（北米、アメリカ...

世界の抗腫瘍薬市場規模・現状・予測（2021年-2027年）

Global Anti-Neoplastic Pharmaceutical Agents Market Size, Status and Forecast 2021-2027
QFJ1-3830 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、抗腫瘍薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ホルモン＆拮抗薬、微生物製品、植物製品、抗腫瘍抗生物質、アルキル化剤、代謝拮抗剤、天然物）、用途別市場規模（肺がん、膀胱がん、乳がん、子宮頸がん...

世界の経口高分子製剤市場規模・現状・予測（2021年-2027年）

Global Oral Macromolecule Formulation Market Size, Status and Forecast 2021-2027
QFJ1-5915 2021年6月 95Pages
QYResearch社発行の本調査レポートでは、経口高分子製剤の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（カプセル、錠剤、液体）、用途別市場規模（病院薬局、小売薬局、オンライン薬局、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日...

世界の経口免疫賦活剤市場規模・現状・予測（2021年-2027年）

Global Oral Immunostimulant Market Size, Status and Forecast 2021-2027
QFJ1-5914 2021年6月 106Pages
QYResearch社発行の本調査レポートでは、経口免疫賦活剤の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（インターロイキン、グルカン、リポ多糖、レバミゾール、イソプリノシン）、用途別市場規模（病院薬局、小売薬局、ドラッグストア、オンライン薬局）...

世界の口腔ケア＆口腔衛生市場規模・現状・予測（2021年-2027年）

Global Oral Care and Oral Hygiene Market Size, Status and Forecast 2021-2027
QFJ1-4623 2021年6月 105Pages
QYResearch社発行の本調査レポートでは、口腔ケア＆口腔衛生の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（歯磨き粉、歯ブラシ、うがい薬、歯科用アクセサリー、義歯製品、歯科補綴物洗浄剤）、用途別市場規模（消費者向け店舗、小売薬局、オンライン配...

世界のオーラルリンス市場規模・現状・予測（2021年-2027年）

Global Oral Rinse Market Size, Status and Forecast 2021-2027
QFJ1-4624 2021年6月 109Pages
QYResearch社発行の本調査レポートでは、オーラルリンスの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（防腐剤、鎮痛剤、抗真菌剤、抗炎症剤）、用途別市場規模（オンライン薬局、ドラッグストア、歯科医院、小売薬局）、主要地域別市場規模（北米、アメ...

世界の栄養補助食品用経口薄膜市場規模・現状・予測（2021年-2027年）

Global Nutraceutical Oral Thin Films Market Size, Status and Forecast 2021-2027
QFJ1-4600 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、栄養補助食品用経口薄膜の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（酸化防止剤、多価不飽和脂肪酸、プレバイオティクス、その他）、用途別市場規模（病院薬局、小売薬局、オンライン薬局、その他）、主要地域...

世界の口腔がん診断市場規模・現状・予測（2021年-2027年）

Global Oral Cancer Diagnosis Market Size, Status and Forecast 2021-2027
QFJ1-4621 2021年6月 106Pages
QYResearch社発行の本調査レポートでは、口腔がん診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（コンピュータ断層撮影（CT）スキャン、磁気共鳴画像（MRI）、ポジトロン放出断層撮影（PET）、超音波検査、生検、X線、内視鏡検査、蛍光画像...

世界の経口抗糖尿病剤市場規模・現状・予測（2021年-2027年） Oral Antidiabetic Agents refer to the oral drugs used to treat type 2 diabetes in patients who uncontrolled by diet and exercise. Currently, there are five distinct classes of hypoglycemic agents available include sulfonylureas, meglitinides, biguanides, thiazolidinediones and alpha-glucosidase inhi…
世界の経口高分子製剤市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Oral Macromolecule Formulation Market The global Oral Macromolecule Formulation market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data int…
世界の経口免疫賦活剤市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Oral Immunostimulant Market The global Oral Immunostimulant market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report m…
世界の栄養補助食品用経口薄膜市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Nutraceutical Oral Thin Films Market The global Nutraceutical Oral Thin Films market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integ…
世界の経口抗糖尿病薬市場規模・現状・予測（2021年-2027年） Diabetes is a chronic disease that occurs when the body cannot effectively use the produced insulin or the pancreas does not produce sufficient insulin. The pancreas is an organ that sits behind the stomach and releases hormones into the digestive system. Diabetes is categorized by increased levels …